AstraZeneca's coronavirus vaccine should only be offered to people who are under 65, Germany's vaccine committee stated in an update to its recommendations, citing a lack of sufficient data to recommend use in older age groups, APA reports citing Sputnik.
"There are currently insufficient data available to assess the vaccine efficacy from 65 years of age," the committee said in the resolution recently released by the German health ministry.
"The AstraZeneca vaccine, unlike the mRNA vaccines, should only be offered to people aged 18-64 years at each stage," it went on to specify.
The comments came as the EU's watchdog, the European Medicines Agency, is expected to finally decide on Friday whether to approve AstraZeneca's COVID-19 vaccine, which is based on chimpanzee adenovirus technology. On Monday, German newspaper Handelsblatt published claims — quickly dismissed by the country's health ministry — that the EMA was on the verge of rejecting AstraZeneca's licensing application across the bloc, claiming it was no more than eight percent effective.